Sun Pharma Backs The First Standardized U.S. Treatment Recommendations For Severe Alopecia Areata

Sun Pharmaceutical said it supports the first standardized U.S. treatment recommendations for adults with severe alopecia areata, published in JAMA Dermatology. The development may support broader clinical standardization in severe AA treatment, but the article provides no financial impact, product-specific data, or sales guidance.